Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Up – Still a Buy?

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) gapped up prior to trading on Wednesday . The stock had previously closed at $25.80, but opened at $27.33. Chugai Pharmaceutical shares last traded at $26.34, with a volume of 19,127 shares.

Chugai Pharmaceutical Trading Up 2.0%

The company has a market capitalization of $86.59 billion, a PE ratio of 32.89 and a beta of 0.63. The business’s fifty day moving average is $26.59 and its two-hundred day moving average is $24.23.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last posted its quarterly earnings results on Friday, October 24th. The company reported $0.23 earnings per share for the quarter. Chugai Pharmaceutical had a return on equity of 20.63% and a net margin of 32.74%.The firm had revenue of $2.26 billion during the quarter. As a group, equities research analysts anticipate that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 EPS for the current year.

Chugai Pharmaceutical Company Profile

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.